{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T11:18:02Z","timestamp":1790680682939,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"vor","delay-in-days":3136,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["molpharm.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Pharmacology"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1124\/mol.116.103267","type":"journal-article","created":{"date-parts":[[2016,3,18]],"date-time":"2016-03-18T02:39:47Z","timestamp":1458268787000},"page":"630-644","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Repurposing Treprostinil for Enhancing Hematopoietic Progenitor Cell Transplantation"],"prefix":"10.1016","volume":"89","author":[{"given":"Zahra","family":"Kazemi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Bergmayr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michaela","family":"Prchal-Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tahereh","family":"Javaheri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madeleine","family":"Themanns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ha T.T.","family":"Pham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang","family":"Strohmaier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronika","family":"Sexl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Freissmuth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Zebedin-Brandl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/mol.116.103267_bib1","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/nature07859","article-title":"Haematopoietic stem cells depend on Galpha(s)-mediated signalling to engraft bone marrow","volume":"459","author":"Adams","year":"2009","journal-title":"Nature"},{"key":"10.1124\/mol.116.103267_bib2","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/nature04247","article-title":"Stem cell engraftment at the endosteal niche is specified by the calcium-sensing receptor","volume":"439","author":"Adams","year":"2006","journal-title":"Nature"},{"key":"10.1124\/mol.116.103267_bib3","first-page":"399","article-title":"Chemotherapy and bone marrow reserve: lessons learned from autologous stem cell transplantation","volume":"17","author":"Aksentijevich","year":"2002","journal-title":"Cancer Biother Radiopharm"},{"key":"10.1124\/mol.116.103267_bib4","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1111\/bph.12445","article-title":"The Concise Guide to PHARMACOLOGY 2013\/14: G protein-coupled receptors","volume":"170","author":"Alexander","year":"2013","journal-title":"Br J Pharmacol"},{"key":"10.1124\/mol.116.103267_bib5","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.4049\/jimmunol.178.3.1628","article-title":"Synthetic prostacyclin analogs differentially regulate macrophage function via distinct analog-receptor binding specificities","volume":"178","author":"Aronoff","year":"2007","journal-title":"J Immunol"},{"key":"10.1124\/mol.116.103267_bib6","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.healun.2013.06.008","article-title":"One-year experience with intravenous treprostinil for pulmonary arterial hypertension","volume":"32","author":"Benza","year":"2013","journal-title":"J Heart Lung Transplant"},{"key":"10.1124\/mol.116.103267_bib7","doi-asserted-by":"crossref","first-page":"28831","DOI":"10.1074\/jbc.M113.464776","article-title":"Recruitment of a cytoplasmic chaperone relay by the A2A adenosine receptor","volume":"288","author":"Bergmayr","year":"2013","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.116.103267_bib8","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.bcmd.2014.02.002","article-title":"Inhibition of DPP4\/CD26 and dmPGE\u2082 treatment enhances engraftment of mouse bone marrow hematopoietic stem cells","volume":"53","author":"Broxmeyer","year":"2014","journal-title":"Blood Cells Mol Dis"},{"key":"10.1124\/mol.116.103267_bib9","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1378\/chest.12-1708","article-title":"An update on pulmonary complications of hematopoietic stem cell transplantation","volume":"144","author":"Chi","year":"2013","journal-title":"Chest"},{"key":"10.1124\/mol.116.103267_bib10","doi-asserted-by":"crossref","first-page":"3074","DOI":"10.1182\/blood-2013-05-503177","article-title":"Prostaglandin-modulated umbilical cord blood hematopoietic stem cell transplantation","volume":"122","author":"Cutler","year":"2013","journal-title":"Blood"},{"key":"10.1124\/mol.116.103267_bib11","doi-asserted-by":"crossref","first-page":"21907","DOI":"10.1016\/S0021-9258(20)88271-4","article-title":"Mutations of GS alpha designed to alter the reactivity of the protein with bacterial toxins. Substitutions at ARG187 result in loss of GTPase activity","volume":"264","author":"Freissmuth","year":"1989","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.116.103267_bib12","doi-asserted-by":"crossref","first-page":"4054","DOI":"10.1182\/blood-2009-03-205823","article-title":"In vivo prostaglandin E2 treatment alters the bone marrow microenvironment and preferentially expands short-term hematopoietic stem cells","volume":"114","author":"Frisch","year":"2009","journal-title":"Blood"},{"key":"10.1124\/mol.116.103267_bib13","first-page":"2330","article-title":"Vascular endothelial growth factor gene expression in colon cancer cells exposed to prostaglandin E2 is mediated by hypoxia-inducible factor 1","volume":"63","author":"Fukuda","year":"2003","journal-title":"Cancer Res"},{"key":"10.1124\/mol.116.103267_bib14","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.stem.2011.02.003","article-title":"Prostaglandin E2 enhances human cord blood stem cell xenotransplants and shows long-term safety in preclinical nonhuman primate transplant models","volume":"8","author":"Goessling","year":"2011","journal-title":"Cell Stem Cell"},{"key":"10.1124\/mol.116.103267_bib15","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/j.cell.2009.01.015","article-title":"Genetic interaction of PGE2 and Wnt signaling regulates developmental specification of stem cells and regeneration","volume":"136","author":"Goessling","year":"2009","journal-title":"Cell"},{"key":"10.1124\/mol.116.103267_bib16","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0014-5793(02)03143-5","article-title":"Chemokine receptor inhibition by AMD3100 is strictly confined to CXCR4","volume":"527","author":"Hatse","year":"2002","journal-title":"FEBS Lett"},{"key":"10.1124\/mol.116.103267_bib17","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/nature11929","article-title":"Differential stem- and progenitor-cell trafficking by prostaglandin E2","volume":"495","author":"Hoggatt","year":"2013","journal-title":"Nature"},{"key":"10.1124\/mol.116.103267_bib18","doi-asserted-by":"crossref","first-page":"5444","DOI":"10.1182\/blood-2009-01-201335","article-title":"Prostaglandin E2 enhances hematopoietic stem cell homing, survival, and proliferation","volume":"113","author":"Hoggatt","year":"2009","journal-title":"Blood"},{"key":"10.1124\/mol.116.103267_bib19","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.bcmd.2012.11.006","article-title":"Recovery from hematopoietic injury by modulating prostaglandin E(2) signaling post-irradiation","volume":"50","author":"Hoggatt","year":"2013","journal-title":"Blood Cells Mol Dis"},{"key":"10.1124\/mol.116.103267_bib20","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1748-1716.2011.02273.x","article-title":"Cyclic AMP is both a pro-apoptotic and anti-apoptotic second messenger","volume":"204","author":"Insel","year":"2012","journal-title":"Acta Physiol (Oxf)"},{"key":"10.1124\/mol.116.103267_bib21","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1124\/jpet.112.200444","article-title":"Role of prostaglandin receptor EP2 in the regulations of cancer cell proliferation, invasion, and inflammation","volume":"344","author":"Jiang","year":"2013","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/mol.116.103267_bib22","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0076-6879(94)38005-8","article-title":"Determination of adenylyl cyclase catalytic activity using single and double column procedures","volume":"238","author":"Johnson","year":"1994","journal-title":"Methods Enzymol"},{"key":"10.1124\/mol.116.103267_bib23","doi-asserted-by":"crossref","first-page":"3010","DOI":"10.1074\/jbc.M007910200","article-title":"Inhibition of adenylyl and guanylyl cyclase isoforms by the antiviral drug foscarnet","volume":"276","author":"Kudlacek","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1124\/mol.116.103267_bib24","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1038\/nature05883","article-title":"Prostaglandin E2 regulates vertebrate haematopoietic stem cell homeostasis","volume":"447","author":"North","year":"2007","journal-title":"Nature"},{"issue":"Suppl 1","key":"10.1124\/mol.116.103267_bib25","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1365-2184.2010.00726.x","article-title":"Pulse exposure of haematopoietic grafts to prostaglandin E2 in vitro facilitates engraftment and recovery","volume":"44","author":"Pelus","year":"2011","journal-title":"Cell Prolif"},{"key":"10.1124\/mol.116.103267_bib26","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1111\/bph.12253","article-title":"To breathe or not to breathe: the haematopoietic stem\/progenitor cells dilemma","volume":"169","author":"Piccoli","year":"2013","journal-title":"Br J Pharmacol"},{"key":"10.1124\/mol.116.103267_bib27","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.1182\/blood-2015-01-607366","article-title":"Enforced fucosylation of cord blood hematopoietic cells accelerates neutrophil and platelet engraftment after transplantation","volume":"125","author":"Popat","year":"2015","journal-title":"Blood"},{"key":"10.1124\/mol.116.103267_bib28","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.stem.2007.08.016","article-title":"Limiting factors in murine hematopoietic stem cell assays","volume":"1","author":"Purton","year":"2007","journal-title":"Cell Stem Cell"},{"key":"10.1124\/mol.116.103267_bib29","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1096\/fj.07-9574LSF","article-title":"Dose translation from animal to human studies revisited","volume":"22","author":"Reagan-Shaw","year":"2008","journal-title":"FASEB J"},{"key":"10.1124\/mol.116.103267_bib30","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.healun.2012.02.025","article-title":"Long-term treatment, tolerability, and survival with sub-cutaneous treprostinil for severe pulmonary hypertension","volume":"31","author":"Sadushi-Koli\u00e7i","year":"2012","journal-title":"J Heart Lung Transplant"},{"key":"10.1124\/mol.116.103267_bib31","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.exphem.2003.12.007","article-title":"Initial human myeloid\/dendritic cell progenitors identified by absence of myeloperoxidase protein expression","volume":"32","author":"Scholz","year":"2004","journal-title":"Exp Hematol"},{"key":"10.1124\/mol.116.103267_bib32","doi-asserted-by":"crossref","first-page":"6477","DOI":"10.4049\/jimmunol.174.10.6477","article-title":"Human lymphoid and myeloid cell development in NOD\/LtSz-scid IL2R gamma null mice engrafted with mobilized human hemopoietic stem cells","volume":"174","author":"Shultz","year":"2005","journal-title":"J Immunol"},{"key":"10.1124\/mol.116.103267_bib33","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.healun.2013.01.1055","article-title":"Children with pulmonary arterial hypertension and prostanoid therapy: long-term hemodynamics","volume":"32","author":"Siehr","year":"2013","journal-title":"J Heart Lung Transplant"},{"key":"10.1124\/mol.116.103267_bib34","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1182\/blood-2013-07-516336","article-title":"Pharmacologic increase in HIF1\u03b1 enhances hematopoietic stem and progenitor homing and engraftment","volume":"123","author":"Speth","year":"2014","journal-title":"Blood"},{"key":"10.1124\/mol.116.103267_bib35","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1146\/annurev.pa.36.040196.002333","article-title":"Complexity and diversity of mammalian adenylyl cyclases","volume":"36","author":"Sunahara","year":"1996","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1124\/mol.116.103267_bib36","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1126\/science.278.5345.1907","article-title":"Crystal structure of the catalytic domains of adenylyl cyclase in a complex with Gsalpha.GTPgammaS","volume":"278","author":"Tesmer","year":"1997","journal-title":"Science"},{"key":"10.1124\/mol.116.103267_bib37","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.bcp.2012.03.012","article-title":"Binding and activity of the prostacyclin receptor (IP) agonists, treprostinil and iloprost, at human prostanoid receptors: treprostinil is a potent DP1 and EP2 agonist","volume":"84","author":"Whittle","year":"2012","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/mol.116.103267_bib38","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.hoc.2010.11.008","article-title":"Hematopoietic stem cell transplantation: an overview of infection risks and epidemiology","volume":"25","author":"Wingard","year":"2011","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1124\/mol.116.103267_bib39","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1124\/pr.110.003517","article-title":"International Union of Basic and Clinical Pharmacology. LXXXIII: classification of prostanoid receptors, updating 15 years of progress","volume":"63","author":"Woodward","year":"2011","journal-title":"Pharmacol Rev"},{"key":"10.1124\/mol.116.103267_bib40","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.stem.2014.01.004","article-title":"Translational research: the path for bringing discovery to patients","volume":"14","author":"Zon","year":"2014","journal-title":"Cell Stem Cell"}],"updated-by":[{"DOI":"10.1016\/j.molpha.2025.100025","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000}}],"container-title":["Molecular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24004863?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026895X24004863?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/mol.116.103267","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T17:21:28Z","timestamp":1740763288000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026895X24004863"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":40,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["S0026895X24004863"],"URL":"https:\/\/doi.org\/10.1124\/mol.116.103267","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.molpha.2025.100025","asserted-by":"object"}]},"ISSN":["0026-895X"],"issn-type":[{"value":"0026-895X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Repurposing Treprostinil for Enhancing Hematopoietic Progenitor Cell Transplantation","name":"articletitle","label":"Article Title"},{"value":"Molecular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/mol.116.103267","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The Author(s)","name":"copyright","label":"Copyright"}]}}